According to Aldeyra Therapeutics 's latest financial reports the company's current EPS (TTM) is -$0.89. In 2022 the company made an earnings per share (EPS) of -$1.06 an increase over its 2021 EPS that were of -$1.07.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.89 | -16.04% |
2022 | -$1.06 | -0.93% |
2021 | -$1.07 | -4.46% |
2020 | -$1.12 | -49.78% |
2019 | -$2.23 | 23.89% |
2018 | -$1.80 | 28.57% |
2017 | -$1.40 | -16.17% |
2016 | -$1.67 | 19.29% |
2015 | -$1.40 | -33.09% |
2014 | -$2.09 | -84.28% |
2013 | -$13.31 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Regeneron Pharmaceuticals REGN | $37.36 | -4,297.75% | ๐บ๐ธ USA |